Learn More
Hereditary pancreatitis (HP) is a rare, early-onset genetic disorder characterized by epigastric pain and often more serious complications. We now report that an Arg-His substitution at residue 117 of the cationic trypsinogen gene is associated with the HP phenotype. This mutation was observed in all HP affected individuals and obligate carriers from five(More)
1. By a method of hepatic venous catheterization previously described, comparative data have been obtained concerning the removal of pneumococci from the splanchnic circulating blood of the intact rabbit in bacteriemias secondary to a dermal infection and in bacteriemias induced by a continuous infusion of organisms into the blood stream. The average(More)
In rabbits subjected to profound damage of the blood-forming tissues by the use of benzene and mechlorethamine hydrochloride, no impairment of efficiency in the splanchnic removal of M. aureus from the blood stream could be demonstrated by a method involving catheterization of the hepatic vein. All evidence continues to indicate that a bacteriemia cannot be(More)
BACKGROUND Management of pancreatic ascites with conservative medical therapy or surgery has met with limited success. Decompression of the pancreatic ductal system through transpapillary stent placement, an alternative strategy, has been reported in only a handful of cases of pancreatic ascites. METHODS We reviewed all cases from 1994 to 1997 in which(More)
A patient with 7 yr of severe disabling chronic epigastric abdominal pain attributed to chronic pancreatitis was seen in consultation before a 95% pancreatectomy for pain control. Previous attempts to identify and treat the pain lead to extensive radiographic, pharmacological, endoscopic, and surgical interventions, including a Roux-en-Y(More)
BACKGROUND & AIMS Hereditary pancreatitis (HP) is an autosomal-dominant disorder with incomplete penetrance characterized by recurrent bouts of severe epigastric pain with onset usually at 5-10 years of age. A genetic linkage study was designed to identify the HP gene. METHODS A 500-member pedigree was constructed from a U.S. kindred centered in eastern(More)
OBJECTIVES Because there are no markers for hereditary pancreatitis (HP), diagnosis has relied on clinical features and inferences. Identification of the HP disease gene locus on chromosome 7q35 provides the first genetic marker for HP, allowing an accurate comparison of the clinical diagnosis of HP with the presence of a high-risk HP haplotype. Our(More)
Diclofenac sodium is a widely used enteric-coated nonsteroidal anti-inflammatory drug. We describe a woman with Hemoccult-positive stools and iron deficiency anemia who developed both a colonic ulcer and a "diaphragm-like" colonic stricture while taking enteric-coated diclofenac. These lesions were evident on colonoscopy but not on barium studies. Biopsy(More)
BACKGROUND Quality of life (QoL) assessment is crucial to assess the severity of dermatological diseases. PURPOSE To construct and validate the first dermatology-specific instrument in French. METHODS Items were generated from the interview of patients. The final self-administered questionnaire, the VQ-Dermato, included 28 questions. Validity in terms(More)
BACKGROUND Hereditary pancreatitis (HP) was defined on a clinical basis alone until the first cationic trypsinogen gene (PRSS1) mutation was discovered through the initial phase of the current Pittsburgh Midwest Multi-Center Pancreatic Study Group (MMPSG) HP study in 1996, making genetic testing available. AIM To evaluate the regional distribution of HP(More)